Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097812
Status:
COMPLETED
Last Update Posted:
2012-04-27
First Post:
2004-11-30
Brief Title:
Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Osteoporosis |
Keywords:
| Name | View |
|---|---|
| osteoporosis osteopenia post-menopausal zoledronic acid | View |